Lauren Tyra

Director/Board Member at Gregor Diagnostics, Inc.

Consumer Services

Finance

Health Technology

Profile

Lauren Tyra is currently the Director at Gregor Diagnostics, Inc. and the Chief Scientific Officer at Green Park & Golf Ventures LLC.
She completed her undergraduate degree at the University of North Texas and her doctorate degree at The University of Texas Southwestern Medical Center in 2017.

Lauren Tyra active positions

Companies	Position	Start
Green Park & Golf Ventures LLC Green Park & Golf Ventures LLC Investment ManagersFinance Green Park & Golf Ventures LLC (Green Park & Golf Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas.	Corporate Officer/Principal	2020-02-29
Gregor Diagnostics, Inc. Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI.	Director/Board Member	-

All active positions of Lauren Tyra

Training of Lauren Tyra

University of North Texas	Undergraduate Degree
The University of Texas Southwestern Medical Center	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lauren Tyra's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Green Park & Golf Ventures LLC Green Park & Golf Ventures LLC Investment ManagersFinance Green Park & Golf Ventures LLC (Green Park & Golf Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas.	Finance
Gregor Diagnostics, Inc. Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI.	Health Technology

See company connections